NCT05521607 is a NA clinical trial of Picterus Jaundice Pro (JP) in Neonatal Jaundice, sponsored by Picterus AS.

Who is sponsoring NCT05521607?

NCT05521607 is sponsored by Picterus AS.

What drugs are being tested in NCT05521607?

Interventions in NCT05521607: Picterus Jaundice Pro (JP).

What condition does NCT05521607 study?

NCT05521607 studies Neonatal Jaundice.

Is NCT05521607 still recruiting?

NCT05521607 is currently recruiting now. Last updated 19 September 2024.

Last reviewed 2024-09-19 · How we verify

NCT05521607

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of a Smartphone-based Screening Tool (Picterus JP) for Neonatal Jaundice (Chicago)

Recruiting now NA Last updated 19 September 2024

What this trial tests

NA trial testing Picterus Jaundice Pro (JP) in Neonatal Jaundice in 250 participants. Currently enrolling.

Timeline

6 January 2023

Primary endpoint
31 October 2024

15 June 2025

Quick facts

Lead sponsor	Picterus AS
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	250
Start date	6 January 2023
Primary completion	31 October 2024
Estimated completion	15 June 2025
Sites	1 location across United States

Drugs / interventions tested

Picterus Jaundice Pro (JP)

Conditions studied

Neonatal Jaundice — all drugs for Neonatal Jaundice →

Sponsor

Picterus AS

Who can join

Adults 1 Day to 14 Days, any sex, with Neonatal Jaundice. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A cross-sectional conductive study at the University of Chicago Medicine facilities (hospital and outreach clinics) to enable high qualitative estimation of bilirubin levels in the blood of newborns, independent of skin color, using Picterus JP.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Neonatal Jaundice

Currently open trials in the same condition.

NCT06963450 — NeoSCB App for Screening Jaundice in Newborns · recruiting
NCT06399146 — Evaluation of Bilirubin Estimates in Newborns From Smartphone Digital Images in a Population in Botswana · NA · recruiting

Other Picterus AS trials

Trials by the same sponsor.

NCT06372093 — Evaluation of Bilirubin Measurements in Newborns From Smartphone Digital Images in a Population in Botswana · NA · completed
NCT05630495 — Validation of an Innovative Neonatal Jaundice Detection System (Picterus) in Indonesia · NA · unknown
NCT05955144 — Clinical Validation of the Screening Tool Picterus JP Using Different Smartphones · NA · unknown
NCT05365399 — Evaluation of a Smartphone-based Screening Tool for Neonatal Jaundice in a Ugandan Population · NA · terminated
NCT05616845 — A mHealth Application as a Screening Tool for Neonatal Jaundice in Filipino Neonates · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05521607 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Picterus AS
Last refreshed: 19 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05521607.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing